104 related articles for article (PubMed ID: 17608465)
1. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells.
Xia C; Schümann J; Emmanuel R; Zhang Y; Chen W; Zhang W; De Libero G; Wang PG
J Med Chem; 2007 Jul; 50(15):3489-96. PubMed ID: 17608465
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.
Chen W; Xia C; Wang J; Thapa P; Li Y; Talukdar A; Nadas J; Zhang W; Zhou D; Wang PG
J Org Chem; 2007 Dec; 72(26):9914-23. PubMed ID: 18020363
[TBL] [Abstract][Full Text] [Related]
3. Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells.
Xia C; Zhou D; Liu C; Lou Y; Yao Q; Zhang W; Wang PG
Org Lett; 2006 Nov; 8(24):5493-6. PubMed ID: 17107055
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effects by chemical modified IGb3 analogues.
Zhou Z; Zhang C; Xia C; Chen W; Zhu H; Shang P; Ma F; Wang PG; Zhang J; Xu W; Tian Z
Mol Cancer Ther; 2011 Aug; 10(8):1375-84. PubMed ID: 21653685
[TBL] [Abstract][Full Text] [Related]
7. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells.
Yin N; Long X; Goff RD; Zhou D; Cantu C; Mattner J; Mezard PS; Teyton L; Bendelac A; Savage PB
ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19175331
[TBL] [Abstract][Full Text] [Related]
8. A divergent approach to the synthesis of iGb3 sugar and lipid analogues via a lactosyl 2-azido-sphingosine intermediate.
Cheng JM; Dangerfield EM; Timmer MS; Stocker BL
Org Biomol Chem; 2014 May; 12(17):2729-36. PubMed ID: 24652424
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness.
Balreira A; Cavallari M; Sá Miranda MC; Arosa FA
Immunobiology; 2010 Jun; 215(6):505-13. PubMed ID: 19651460
[TBL] [Abstract][Full Text] [Related]
10. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
[TBL] [Abstract][Full Text] [Related]
11. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.
Porubsky S; Speak AO; Luckow B; Cerundolo V; Platt FM; Gröne HJ
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5977-82. PubMed ID: 17372206
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.
Zajonc DM; Savage PB; Bendelac A; Wilson IA; Teyton L
J Mol Biol; 2008 Apr; 377(4):1104-16. PubMed ID: 18295796
[TBL] [Abstract][Full Text] [Related]
13. Chemoenzymatic syntheses of iGb3 and Gb3.
Yao Q; Song J; Xia C; Zhang W; Wang PG
Org Lett; 2006 Mar; 8(5):911-4. PubMed ID: 16494472
[TBL] [Abstract][Full Text] [Related]
14. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal glycosphingolipid recognition by NKT cells.
Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
[TBL] [Abstract][Full Text] [Related]
16. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
Li Y; Zhou D; Xia C; Wang PG; Levery SB
Glycobiology; 2008 Feb; 18(2):166-76. PubMed ID: 18048405
[TBL] [Abstract][Full Text] [Related]
17. [The regulatory role of V alpha 14 NKT cells in innate and acquired immune response].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2109-16. PubMed ID: 12518422
[No Abstract] [Full Text] [Related]
18. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
20. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
